The Beacon (Kansas City) covered a Missouri judge's decision to temporarily stop a law that forbids Missouri pharmacists from discussing ivermectin and hydroxychloroquine with their patients.
Forbes profiles the Hamilton Lincoln Law Institute and its director Theodore H. Frank. William Baldwin explains how class action settlements work, and why Ted “is not a popular figure in the litigation bar.”
HLLI filed suit on behalf of a pharmacist who challenges a new Missouri law that would prevent pharmacists in the state from communicating with physicians or patients to dispute the effectiveness of ivermectin or hydroxychloroquine for human use as a COVID-19 treatment.
![<em>Stock v. Gray</em> et al. [Missouri Board of Pharmacy]](https://hlli.org/wp-content/uploads/2022/07/OSU-Pharmacist-768x614.jpg)